Seer, Inc. announces an Equity Buyback for $25 million worth of its shares.
May 08, 2024 at 04:16 pm EDT
Share
Seer, Inc. (NasdaqGS:SEER) announces a share repurchase program. Under the program, the company will repurchase up to $25 million worth of its Class A common stock. The purpose of repurchase program is to enhance long-term stockholder value.
Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.
SEER, INC. 
